Market Tracker

12/18 7:14am ET

Celgene Corp (NASDAQ:CELG)

112.82
Data as of Dec 17
 +2.73 / +2.48%
Today’s Change
66.85
Today|||52-Week Range
119.84
+33.54%
Year-to-Date

Today’s Trading

Previous close110.09
Today’s open110.21
Day’s range-- - 113.11
Volume4,870,086
Average volume (3 months)5,088,524
Market cap$87.9B
Dividend yield--
Data as of 12/17/2014

Growth & Valuation

Earnings growth (last year)+2.12%
Earnings growth (this year)+23.79%
Earnings growth (next 5 years)+25.83%
Revenue growth (last year)+19.49%
P/E ratio59.1
Price/Sales10.78
Price/Book16.14

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.63+0.91%
NVONovo Nordisk+0.29+0.67%
BMYBristol-Myers Squibb+1.50+2.60%
LLYEli Lilly and Co+1.02+1.47%
Data as of 12/17/2014

Financials

Next reporting dateJanuary 29, 2015
EPS forecast (this quarter)$1.00
Annual revenue (last year)$6.5B
Annual profit (last year)$1.4B
Net profit margin22.36%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts